The Women's Cancers Program is dedicated to advancing our understanding of malignancies that disproportionately affect women, including reproductive cancers (endometrial, ovarian, cervical), breast cancer and more.
More About Us
Our team members are discovering the drivers of cancer development and metastasis, developing new therapies, and uncovering mechanisms that underpin therapeutic resistance. Our efforts are aimed at improving outcomes for every stage of difficult-to-treat gynecologic diseases and breast cancers.
Through interdisciplinary collaboration across our Cancer Institute and Cancer Sciences Department, we take a comprehensive approach to tackling the biological complexity of gynecologic cancers.
Focus Areas